A rare-disease entrepreneur follows an unconventional drug development path

Monday, October 15, 2018 - 01:24 in Mathematics & Economics

In 2012, Ethan Perlstein challenged the academic status quo. Now as CEO of the start-up Perlara, can he do the same for the biotech industry?

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net